Recipient organisationNIHR Sheffield Biomedical Research Centre
NIHR supportRecorded as supported by this research centre
PeriodJan 2025 — Apr 2026
In plain English
AI plain-English summary
Half of all people with diabetes develop nerve damage, and for many, the first sign is a burning, electric-shock pain in their feet that现有 treatments barely touch. Current painkillers for this condition—called painful diabetic neuropathy—reduce symptoms only slightly and often cause side effects, partly because scientists do not understand why some people with nerve damage feel pain while others feel nothing at all. This study tests a specific idea: that extra blood vessels in the skin release substances that make pain-sensing nerves more sensitive. The researchers will recruit 80 participants split into four groups—people with painful neuropathy, painless neuropathy, diabetes without neuropathy, and healthy controls—and take two small skin biopsies from each person’s thigh to count blood vessels and measure nerve activity. If the link between extra skin blood vessels and pain is confirmed, it would give drug developers a clear biological target. Treatments could then aim to quiet those blood vessels or block the substances they release, offering patients a more effective option than today’s painkillers.
View original technical description
Diabetic Peripheral Neuropathy (DPN) affects up to half of people with diabetes and can be either painless or painful. Painful-DPN causes distressing sensations like burning, electric shocks, cold pain, and tingling, particularly in the feet and legs. These sensations can be severe and hard to treat. Current treatments only reduce the pain slightly and often come with side effects. This is partly because we don’t fully understand why some people with DPN experience pain while others don’t. One way to study Painful-DPN is by taking small skin biopsy samples from the leg to examine the pain-sensing nerves and surrounding blood vessels. We think these blood vessels release substances that make the nerves more sensitive, increasing pain signals. However, more research is needed to understand why people with Painful-DPN have more blood vessels in their skin and how this relates to their pain. This study aims to explore why people with Painful-DPN have more blood vessels in their skin and whether this contributes to their pain. We will recruit 80 participants, divided into four groups of 20: Painful-DPN, Painless-DPN, people with diabetes but no DPN, and people without diabetes or nerve damage. All participants will undergo detailed nerve function tests and have two small skin biopsies (3mm) taken from the thigh under local anaesthetic. No stitches are needed for the biopsy, and only a simple dressing will be applied afterward.
Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.
Is something wrong? Let us know